2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol
C23H27N5OS — CID 167503996
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol
2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol (PubChem CID 167503996) has the molecular formula C23H27N5OS and a molecular weight of 421.57 g/mol. Its IUPAC name is 2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol.
Molecular Properties
| Compound Name | 2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol |
|---|---|
| PubChem CID | 167503996 |
| Molecular Formula | C23H27N5OS |
| Molecular Weight | 421.57 g/mol |
| Exact Mass | 421.19 |
| IUPAC Name | 2-[6-[(3R)-3-(cyclobutylamino)-3-methylpyrrolidin-1-yl]pyridazin-3-yl]-5-(2-methyl-1,3-thiazol-5-yl)phenol |
| SMILES | Cc1ncc(-c2ccc(-c3ccc(N4CC[C@@](C)(NC5CCC5)C4)nn3)c(O)c2)s1 |
| InChI | InChI=1S/C23H27N5OS/c1-15-24-13-21(30-15)16-6-7-18(20(29)12-16)19-8-9-22(27-26-19)28-11-10-23(2,14-28)25-17-4-3-5-17/h6-9,12-13,17,25,29H,3-5,10-11,14H2,1-2H3/t23-/m1/s1 |
| InChIKey | RPLBNOJGQIALEI-HSZRJFAPSA-N |
| XLogP | 4.39 |
| TPSA | 74.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.57 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167503996 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.